Miss Rebecca Wallace

Overview

I'm a third year PhD student working on developing new caner virotherapy platforms. 

In my lab, supervised by Professor Alan Parker, we develop new adenovirus-based vectors, which can be used as cancer therapies, gene-therapy- or vaccine vectors. I am funded by CRUK and co-supervised by Dr Carly Bliss and Professor Awen Gallimore. 

In my thesis, titled "Development of Precision Virotherapies Capapble of Evading Host Anti-Vector Immunity" I will be exploring how population immunity to Ad5, the most commonly used Adenovirus vector, can be circumvented to better deliver therapies to patients.